Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowA biotechnology company headquartered in France has chosen central Indiana for its second U.S.-based manufacturing facility.
Orano Med LLC plans to initially invest more than $15 million to acquire and equip the former Mainstay building in Brownsburg and create about a dozen jobs.
The company says the facility will be used to manufacture and distribute radiopharmaceuticals to treat cancer. The therapies will be delivered to hospitals throughout the country.
“This new facility is a major step of our development. It demonstrates our commitment to offer innovative 212Pb-based cancer therapies to patients in North America,” Julien Dodet, chief executive officer of Orano Med, said in a news release. “Brownsburg was an obvious choice for us, and we look forward to continuing our work with the city.”
Debbie Cook, interim co-town manager and economic development director for Brownsburg, tells Inside INdiana Business the company plans to add 10 jobs in 2022 with an average wage of $45 per hour. The company also anticipates adding more jobs in a few years.
Orano Med did not provide a timeline for the facility’s opening. The company’s first U.S. facility is located in Plano, Texas.
Inside INdiana Business has reached out for additional details on the project, but has not yet received a response.
Please enable JavaScript to view this content.
Im always a little skeptical about companies that make BIG job and development announcements but give very limited if any detail.Be that as it may, its always good to hear of economic growth throughout the metro area and this would be a good thing for the suburb of Brownsburg.Indys doughnut cities are definitely competing and positioning themselves for economic growth and quality of life.